26 related articles for article (PubMed ID: 8377986)
21. A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical response.
Jacobs AJ; Fer M; Su FM; Breitz H; Thompson J; Goodgold H; Cain J; Heaps J; Weiden P
Obstet Gynecol; 1993 Oct; 82(4 Pt 1):586-93. PubMed ID: 8377986
[TBL] [Abstract][Full Text] [Related]
22. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
Wong JY; Shibata S; Williams LE; Kwok CS; Liu A; Chu DZ; Yamauchi DM; Wilczynski S; Ikle DN; Wu AM; Yazaki PJ; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5842-52. PubMed ID: 14676105
[TBL] [Abstract][Full Text] [Related]
23. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
24. Radiocolloids in the treatment of ovarian cancer.
Rosenshein NB; Leichner PK; Vogelsang G
Obstet Gynecol Surv; 1979 Sep; 34(9):708-20. PubMed ID: 386194
[TBL] [Abstract][Full Text] [Related]
25.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
